187 related articles for article (PubMed ID: 5131655)
1. [Chologonic and choleretic action of the Soviet preparation xylite].
Grancharov VP
Vopr Pitan; 1971; 30(6):18-20. PubMed ID: 5131655
[No Abstract] [Full Text] [Related]
2. [Effect of xylite on hepatic and pancreatic function in biliary pathology].
Rafes IuI; Sheleketina II; Voroteliak VS; Kulikova ZS; Mel'nichenko LIa
Vrach Delo; 1972 Feb; 2():10-4. PubMed ID: 5084716
[No Abstract] [Full Text] [Related]
3. [Choleretic effect of Bulgarian rose oil].
Tashev TA; Belousov AS; Gryneharov VP; Zhigalova MF
Klin Med (Mosk); 1970 Aug; 48(8):57-61. PubMed ID: 5476044
[No Abstract] [Full Text] [Related]
4. [Xylitol as a choleretic and cholecystokinetic agent].
Gruncharov V
Vutr Boles; 1973; 12(2):69-73. PubMed ID: 4713058
[No Abstract] [Full Text] [Related]
5. [Assessment of the cholagogic effect of sunflower seed oil and magnesium sulfate on the basis of the urocholecystokinin level].
Popova EA; Gol'tiakova TV
Sov Med; 1969 Apr; 32(4):57-62. PubMed ID: 5378880
[No Abstract] [Full Text] [Related]
6. [Trial and evaluation of a new hepatoprotector, choleretic and antispasmodic preparation].
Fernández Navarro MD; García Pérez M; Arias Vallejo E
Rev Esp Enferm Apar Dig; 1972 Oct; 38(4):503-10. PubMed ID: 4629092
[No Abstract] [Full Text] [Related]
7. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
Marchettini G; Maggi P; Benvenuti C
Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683
[No Abstract] [Full Text] [Related]
8. [Clinical classification of current choleretic preparations].
Skakun NP
Vrach Delo; 1965 Aug; 8():26-9. PubMed ID: 5870987
[No Abstract] [Full Text] [Related]
9. [Odeston in treatment of chronic diseases of hepatobiliary system].
Nasonova SV; Lebedeva OI
Voen Med Zh; 2001 Feb; 322(2):49-53. PubMed ID: 11338822
[No Abstract] [Full Text] [Related]
10. [Amphocholeretic effect of Fumaria officinalis].
Fiegel G
Z Allgemeinmed; 1971 Dec; 47(34):1819-20. PubMed ID: 5134143
[No Abstract] [Full Text] [Related]
11. [Clinical trial of an hepatobiliary analeptic agent].
Chapuy H; Jeune M; Sambin P; Girard M
J Med Lyon; 1971 Jun; 52(211):1025-34. PubMed ID: 5138331
[No Abstract] [Full Text] [Related]
12. [A new choleretic mixture (hydro- and cytocholeretic)].
Boisson J; Albot G
Actual Hepatogastroenterol (Paris); 1966; 2(4):XXIX-XXXI. PubMed ID: 5983695
[No Abstract] [Full Text] [Related]
13. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].
Dehtiar'ova II; Chernenko VV; Anokhina HA; Opanasiuk ND; Pavlik-Novol's'kyĭ T; Haĭsenko AV
Lik Sprava; 1995; (9-12):47-8. PubMed ID: 8983789
[No Abstract] [Full Text] [Related]
14. [Current status of hepatic and biliary drug therapy. Part I].
Donatelli L; Marmo E
Clin Ter; 1976 Mar; 76(5):395-409. PubMed ID: 791566
[No Abstract] [Full Text] [Related]
15. [Cholagogic agents].
Pasichnyk IKh
Farm Zh; 1978; (2):39-43. PubMed ID: 658339
[No Abstract] [Full Text] [Related]
16. [Imecromone: a new choleretic with antispastic action on Oddi's sphincter. Clinical pharmacology and clinico-statistical study].
Cremoncini C; Tominz L
Minerva Med; 1968 Oct; 59(82):4359-68. PubMed ID: 5683717
[No Abstract] [Full Text] [Related]
17. [Treatment of chronic inflammatory diseases of the biliary tract in children with the new choleretic drug Stachyren].
Shmorgun SS; Zinchenko TV; Kuz'menko IA
Farm Zh; 1971; 26(6):48-50. PubMed ID: 5150543
[No Abstract] [Full Text] [Related]
18. [Indications and contraindications of choleretic therapy].
Grossi F
Clin Ter; 1974; 70(2):108-9. PubMed ID: 4409826
[No Abstract] [Full Text] [Related]
19. [Hepatobiliary lesions in Crohn's disease and conservative methods of treatment].
Grigor'eva GA; Meshalkina NIu
Eksp Klin Gastroenterol; 2013; (6):3-6. PubMed ID: 24772851
[No Abstract] [Full Text] [Related]
20. [The chologenic and choleretic action of sorbitol].
Grancharov V
Vopr Pitan; 1973; 32(2):50-4. PubMed ID: 4782923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
